Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
CNS Drugs|February 6, 2016
Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in SchizophreniaThomas W Weickert, Katherine M Allen, Cynthia S Weickert
BMC Neuroscience|February 17, 2012
Developmental changes in human dopamine neurotransmission: cortical receptors and terminatorsDebora A Rothmond, Cynthia S Weickert, Maree J Webster
The European Journal of Neuroscience|June 13, 2009
Changes in alternative brain-derived neurotrophic factor transcript expression in the developing human prefrontal cortexJenny Wong, Maree J Webster, Hope Cassano, et al.
Disease Markers|October 30, 2013
Biomarkers in schizophrenia: a brief conceptual considerationCynthia S Weickert, Thomas W Weickert, Anil Pillai, et al.
Schizophrenia Research|July 13, 2011
Transcranial direct current stimulation influences probabilistic association learning in schizophreniaAns Vercammen, Jacqueline A Rushby, Colleen Loo, et al.
Journal of Psychiatry & Neuroscience : JPN|December 2, 2009
Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical developmentKwang H Choi, Megan E Zepp, Brandon W Higgs, et al.
Synapse (New York, N.Y.)|February 8, 2013
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the ratKaterina Zavitsanou, Victoria S Dalton, Adam K Walker, et al.
Archives of Women'S Mental Health|July 12, 2024
Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognitionBodyl A Brand, Janna N de Boer, Elske J M Willemse, et al.
Pageof 3